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BACKGROUND: Angiomyxoma is a benign proliferative mesenchymal tumor and a very rare mass in 
the larynx. There is not enough information about the etiology, clinical finding, treatment and prognosis 
of laryngeal angiomyxoma. 
CASE DETAILS: A 52 years old man presented with respiratory distress. Also, he had suffered from 
dysphagia, dysphonia, cough, and obstructive sleep apnea in the supine position for 6 months. He was 
operated on via transoral approach under general anesthesia with orotracheal intubation. The mass was 
encapsulated and completely removed. The histopathologic diagnosis was reported as angiomyxoma. 
CONCLUSION: Angiomyxoma should be considered in the differential diagnosis of the larynx masses. 
The treatment of angiomyxomas of the larynx is surgical. The mass can be usually excised intraorally or 
endoscopically. 
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INTRODUCTION   
 
Angiomyxoma is a benign proliferative 
mesenchymal tumor. The mass appears very 
extremely rare in the larynx (1-3). Therefore, there 
is not enough information about the etiology, 
clinical finding, treatment and prognosis of 
laryngeal angiomyxoma.  To the best of our 
knowledge, only three cases regarding 
angiomyxoma of the larynx have been reported in 
the literature (1-3). Herein, we described a case 
with angiomyxoma located at the right 




A 52 years old man presented with respiratory 
distress in our outpatient clinic in 20 April 2012. 
Also, he had suffered from dysphagia, dysphonia, 
cough, and obstructive sleep apnea in the supine 
position for 6 months. He had no history of a 
systemic disease, and was not and alcohol user. He 
had been smoking a packet of cigarette for 35 
years. There was no history of trauma. Endoscopic 
examination revealed a large smooth surface 
polypoid, well-circumscribed mass based in the 
right supraglottic area of the larynx that obstructed 
most of the view of the rima glottidis and moving 
during respiration and phonation (Figure 1). The 
remainder of the clinical examination was 
unremarkable. Computed tomography scan 
showed a well-defined, enhancing solid mass, 
measuring 45×30 mm and narrowing the airway 
space and originating from the supraglottic area of 
the larynx (Figure 2).  
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Figure 1: (A) Endoscopic appearance of the 
angiomyxoma in the right supraglottic area of the 
larynx. (B) Intraoperative the view of the 




Figure 2: (A) Axial and (B) coronal contrast-
enhanced CT scan demonstrated solid mass 
narrowing the airway space and originating from 
the supraglottic area of the larynx 
 
Pre-operative informed consent was obtained from 
the patient. He was operated on via transoral 
approach under general anesthesia with 
orotracheal intubation. The polypoid mass was at 
the right aryepiglottic fold with a broad base. It 
was encapsulated and completely removed in 25 
minutes (Figure 3). After surgery, the true vocal 
cords were normal. On macroscopic examination, 
the specimen measured 4.5x3.0x2.5 cm and was 
well circumscribed and encapsulated with a 
glistening surface. Histopathologic examination of 
the mass revealed that the tumor was characterized 
by a spindle-shaped proliferation or satellite cells 
widely separated by loose, and also myxoid 
stroma including a prominent vascular component. 
The spindle cells showed no nuclear atypia or 
mitoses.  Immunostaining for S-100 protein and 
muscle-specific antigen was negative. Vascular 
component was found positive with cluster of 
differentiation (CD) 34 (Figure 4). The 
histopathologic diagnosis was reported as 
angiomyxoma. Postoperatively, no complication 
was encountered and no recurrence was seen 




Figure 3: Postoperatively, the view of a well-




Figure 4: Spindle-shaped or stellate cells widely 
separated by loose, myxoid stroma (Hematoxylin-
Eosin X40)( small figure: vascular component 




Steeper and Rosai (4) described aggressive 
angiomyxomas of the female pelvis and perineum 
arising from mesenchymal cells. Angiomyxoma of 
the larynx is understood to be counterpart of these 
tumors (1-3). The presenting symptoms of 
larengeal angiomyxoma are similar to many of the 
larengeal masses, and these include dysphagia, 
dysphonia, dyspnea, cough, respiratory distress 




and obstructive sleep apnea (1, 2). It may be 
caused by airway obstruction requiring emergency 
tracheotomy. Endoscopic examination of the 
larenx usually reveals a well circumscribed, 
smooth and polypoidal mass (1, 2). Radiological 
imaging methods can be useful in determining the 
origin and extent of the lesion. 
Histologically, angiomyxomas consist of 
spindle-shaped or stellate cells widely separated 
by loose, myxoid stroma, and a prominent 
vascular component. Immunohistochemically, 
aggressive angiomyxomas of pelvi-perineal 
regions have been shown positive majority of 
tumors for desmin, vimentin, CD44, CD34, 
oestrogen receptors, and smooth muscle actin. 
They are negative for S-100 protein and muscle-
specific antigen (2, 5, 6). In our case, the only 
similarity with the pelvi-perineal form was 
negative for S-100 protein, muscle-specific 
antigen, and positive for CD 34. 
The differential diagnosis of larengeal 
angiomyxoma includes many benign and 
malignant masses in the larenx. Internal 
laryngocele, fibroepithelial polyps, myxomas, 
myxoid neurofibromas, schwannomas, 
rhabdomyosarcomas, myxoid chondrosarcomas, 
myxoid liposarcomas, myxoid variant of 
malignant fibrous histiocytoma, nerve sheath 
myxoma low-grade myxofibrosarcomas, and other 
soft tissue tumors, all should be considered  
differential diagnosis (1,4). 
The treatment of angiomyxomas of the larynx 
is surgical. The mass can usually be excised 
intraorally or endoscopically, but an external 
approach may occasionally be required (1, 2). 
Izadi et al. (1) removed the mass with a CO2 laser. 
Sylvester et al. (2) operated via laryngofissure 
approach and covering tracheostomy. Their patient 
was decannulated one week postoperatively and 
later discharged from the hospital. We excised in 
the mass intraorally and did not apply 
tracheostomy. The patient was discharged from 
the hospital on the second day after surgery. The 
use and effect of radiotherapy and chemotherapy 
in treatment for angiomyxoma of the larynx is 
unknown, but chemotherapy and radiotherapy are 
not effective for aggressive angiomyxomas of the 
pelvis (2). 
In conclusion, angiomyxoma is a benign and 
a very extremely rare tumor of the larynx and 
should be considered in the differential diagnosis 
of the larynx masses. The treatment of 
angiomyxomas of the larynx is surgical and the 
mass can usually be excised intraorally or 
endoscopically. Although angiomyxoma is a 
benign tumor, it occasionally behaves 
aggressively. Since angiomyxoma has a potential 
for local recurrence or metastasis, we recommend 
periodic control examinations and long-term close 
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